PIPELINE HIGHLIGHTS
Ischemic Heart Disease is one of the widely researched conditions during 2020 with 39 companies actively focusing on realizing pipeline’s potential. Development of Ischemic Heart Disease medicines is identified as integral to the strategy of the majority of companies operating in the industry.
Global Ischemic Heart Disease market presents promising new product pipeline with NME Projects, pivotal trials, and rapidly phase-advancing therapeutic candidates. Increasing number of companies are assessing the feasibility of developing treatment options for Ischemic Heart Disease.
Read more .. https://www.businesswire.com/news/home/20200730005440/en/Global-Ischemic-Heart-Disease-Pipeline-2020–